2014
DOI: 10.1038/jhh.2014.25
|View full text |Cite
|
Sign up to set email alerts
|

Suitability of antiplatelet therapy in hypertensive patients

Abstract: Antiplatelet therapy (AT) is indicated in hypertensive patients with increased cardiovascular risk. The literature about the adequate or inadequate prescription of AT is scarce. We conducted a prospective descriptive study to quantify therapeutic inertia and non-guideline-recommended prescription (NGRP) of AT (aspirinor clopidogrel or both), and to assess associated factors, calculating the adjusted odds ratios (ORs) from multivariate models. In 2007-2009, 712 primary health-care hypertensive patients in a Spa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 38 publications
0
7
0
Order By: Relevance
“…From the individualized analysis of each of these variables, based on their measures of association according to the odds ratios obtained (Table 1), we will be able to design strategies focused on reducing non-adherence in these complex patients to improve control of their chronic diseases. Examination of other studies found no consistency regarding the relationship between non-adherence and dependent socioeconomic, demographic and work-family factors [5][6][7][8][9][10][11][12][13][14][15][16], although all the authors agree that non-adherence is associated with greater therapeutic complexity and a poorer doctor-patient relationship [17][18][19][20][21][22][23][24][25].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…From the individualized analysis of each of these variables, based on their measures of association according to the odds ratios obtained (Table 1), we will be able to design strategies focused on reducing non-adherence in these complex patients to improve control of their chronic diseases. Examination of other studies found no consistency regarding the relationship between non-adherence and dependent socioeconomic, demographic and work-family factors [5][6][7][8][9][10][11][12][13][14][15][16], although all the authors agree that non-adherence is associated with greater therapeutic complexity and a poorer doctor-patient relationship [17][18][19][20][21][22][23][24][25].…”
Section: Discussionmentioning
confidence: 99%
“…In other studies, the most consistent factors found to be associated with greater pharmacological non-adherence are those dependent on therapeutic complexity, such that patients with multiple diseases and multiple medications have a higher probability of nonadherence to pharmacological treatment [17][18][19][20][21][22][23][24][25]. Few studies use a holistic approach to address therapeutic adherence in chronic patients, as most studies focus on specific chronic diseases such as hypertension, DM, dyslipidaemia, depression or osteoporosis [5][6][7][8][9][17][18][19][20][21][22][23][24][25].…”
Section: Introductionmentioning
confidence: 85%
See 1 more Smart Citation
“…In 2001, Phillips introduced the concept of clinical inertia, defining it as failure by the physician to initiate or intensify treatment when this action was indicated . This inertia, coupled with poor medication adherence by the patient, is considered the main cause of poor control of chronic diseases such as hypertension .…”
Section: Introductionmentioning
confidence: 99%
“…The study population was formed by diabetic patients admitted via the ED in the Valle de Elda healthcare area (Valencian community), an industrial area with 198,090 inhabitants with a low-to-medium socioeconomic level ( Martínez-Orozco et al, 2015 ). The ED of Elda Hospital (a public institution) tends to about 160 general emergency cases daily among the adult population, not including obstetric and gynaecologic cases ( Carbonell Torregrosa et al, 2014 ).…”
Section: Methodsmentioning
confidence: 99%